Fagron

Fagron OCF Margin

The Operating Cash Flow Margin of Fagron (FAGR.BR) as of Oct 10, 2026 is 13.47 %. In the previous year, Operating Cash Flow Margin was 12.60 % — a change of 6.90% (higher).

OCF Margin

13.47 %

YoY

6.90%

Last updated:

Operating Cash Flow Margin of Fagron is 2025 13.47 % . Operating Cash Flow Margin of Fagron was 2024 12.60 % . It decreases by 6.90% higher compared to the previous year.

The Fagron OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
15.54 EUR
Jan 1, 2019
14.43 EUR
Jan 1, 2020
16.72 EUR
Jan 1, 2021
13.67 EUR
Jan 1, 2022
16.01 EUR
Jan 1, 2023
14.07 EUR
Jan 1, 2024
12.60 EUR
Jan 1, 2025
13.47 EUR
The Fagron OCF Margin history
YEAROCF MarginYoY
13.47 %+6.90%
12.60 %-10.45%
14.07 %-12.07%
16.01 %+17.11%
13.67 %-18.26%
16.72 %+15.84%
14.43 %-7.09%
15.54 %-19.43%
19.28 %+20.49%
16.00 %+3.25%
15.50 %-31.87%
22.75 %—
Access this data via the Eulerpool API

Fagron Stock analysis

What does Fagron do? Fagron NV is an internationally operating company that focuses on the development and production of customized medications for pharmacies and hospitals. The company was founded in 1990 in Rotterdam, Netherlands. The beginnings of Fagron NV were in the Netherlands, where the company was established as Roterodamum Chemie BV. In the late 1990s, the company was converted into a holding company called Arseus NV, which later received the name Fagron. In 2012, Fagron was listed on the Euronext stock exchange in Brussels. Fagron operates globally and has locations in Europe, North America, Latin America, the United Arab Emirates, Asia, and Australia. Fagron's business model is based on the production of specialized medications for individual patient needs. The company offers a wide range of pharmaceutical active ingredients, raw materials, and processing services. There is also the possibility to develop and manufacture customized formulations tailored to the needs of patients. Fagron not only manufactures customized medications but also provides training and support for pharmacies and hospitals. Fagron operates in three main divisions: Specialty Pharma (hospital care), Community Pharma (prescription and non-prescription medications), and Compounding Services (custom formulations). The Specialty Pharma division specializes in medications for use in hospitals. It offers a wide range of products that can be used in the treatment of conditions such as cancer, HIV, and tuberculosis. These medications are manufactured in various dosage forms, such as injections, infusions, and tablets. The Community Pharma division focuses on prescription and non-prescription medications. Both branded and generic medications are offered. These are delivered directly to pharmacies, hospitals, and clinics. The Compounding Services division specializes in the production of customized medications. Fagron works closely with pharmacies and hospitals to meet individual needs. This includes, for example, the manufacture of medications in specific dosages or the combination of several active ingredients in a custom formulation. Fagron offers a wide range of products, including hormones, pain medications, cancer drugs, medications for the treatment of skin diseases, ophthalmic products, and anti-infectives. Pharmaceutical active ingredients and raw materials are also offered. Overall, Fagron is a global leader in the production of customized medications. It has extensive experience and expertise in the manufacturing of pharmaceutical formulations and offers a wide range of products and services. The various divisions of Fagron allow the company to meet the diverse needs of its customers and maintain its position as a leading company in the pharmaceutical industry. Fagron is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fagron stock

Operating Cash Flow Margin of Fagron is 13.47 % in 2025.

Operating Cash Flow Margin of Fagron changed from 12.60 % to 13.47 %, representing a 6.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Fagron since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Fagron with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Fagron

All Key Metrics — Fagron